Cellebrite DI Ltd
NASDAQ:CLBT
Cellebrite DI Ltd
Cellebrite DI Ltd. has carved a niche for itself in the digital intelligence arena, becoming a beacon for law enforcement and government agencies worldwide. Born in Petah Tikva, Israel, the company began its journey focusing on mobile data transfer technology before pivoting to one of the most critical aspects of modern policing—extracting and analyzing data from digital devices. Cellebrite's flagship product, the Universal Forensic Extraction Device (UFED), allows investigators to retrieve a plethora of data from smartphones, tablets, and other devices. This capability is crucial in solving crimes, making Cellebrite an indispensable partner for agencies tackling everything from cybercrime to terrorism.
The company’s business model thrives on providing not just the hardware and software tools but also ongoing support and training services. This creates a steady stream of recurring revenue, as agencies continually rely on Cellebrite for updates in response to the ever-evolving digital landscape. Additionally, their subscription-based offerings grant clients access to the latest forensic advancements, embedding Cellebrite deeper into their operational frameworks. By focusing on combining comprehensive data solutions with robust client support, Cellebrite ensures its position as a leader in the digital intelligence domain, weaving its technology into the very fabric of modern investigative processes.
Cellebrite DI Ltd. has carved a niche for itself in the digital intelligence arena, becoming a beacon for law enforcement and government agencies worldwide. Born in Petah Tikva, Israel, the company began its journey focusing on mobile data transfer technology before pivoting to one of the most critical aspects of modern policing—extracting and analyzing data from digital devices. Cellebrite's flagship product, the Universal Forensic Extraction Device (UFED), allows investigators to retrieve a plethora of data from smartphones, tablets, and other devices. This capability is crucial in solving crimes, making Cellebrite an indispensable partner for agencies tackling everything from cybercrime to terrorism.
The company’s business model thrives on providing not just the hardware and software tools but also ongoing support and training services. This creates a steady stream of recurring revenue, as agencies continually rely on Cellebrite for updates in response to the ever-evolving digital landscape. Additionally, their subscription-based offerings grant clients access to the latest forensic advancements, embedding Cellebrite deeper into their operational frameworks. By focusing on combining comprehensive data solutions with robust client support, Cellebrite ensures its position as a leader in the digital intelligence domain, weaving its technology into the very fabric of modern investigative processes.
ARR Growth: Cellebrite's Annual Recurring Revenue (ARR) grew 21% in 2025 to $481 million, factoring in the Corellium acquisition. Organic ARR growth was 17%.
Revenue & Cash Flow: Full-year revenue reached $475.7 million, up 19%, with free cash flow at $160 million and a 34% margin, both showing strong year-on-year growth.
Guidance Raised: Management expects ARR growth to reaccelerate in 2026 to 18–19%, with revenue guided between $565 million and $571 million for the year.
Product Adoption: 55% of the digital forensics base has converted to Inseyets, exceeding the company's 50% target. Guardian cloud solutions continue to grow rapidly.
Strategic Moves: Corellium acquisition completed and SCG Canada drone forensics deal announced, expanding Cellebrite's platform and addressable market.
Federal Segment Recovery: U.S. Federal segment expected to return to growth and exceed company rates in 2026 after a flat 2025.
AI & Innovation: Continued investment in AI and agentic applications, with management highlighting new monetization opportunities anticipated for 2026.
